<<

J Am Board Fam Pract: first published as 10.3122/jabfm.10.5.370 on 1 September 1997. Downloaded from BRIEF REPORTS After Long-Term Use of an -Converting Inhibitor

Adriana]. Pavietic, MD

Angioedema is an uncommon of cyclobenzaprine, her angioedema was initially be­ angiotensin-converting enzyme (ACE) inhib­ lieved to be an allergic reaction to this , and itors. Its frequency ranges from 0.1 percent in pa­ it was discontinued. She was also given 125 mg of tients on , , and to 0.5 intramuscularly. Her an­ percent in on . l Most cases are gioedema did not improve, and she returned to mild and occur within the first week of treat­ the clinic the following day. She was seen by an­ ment. 2-4 Recent reports indicate that late-onset other , who discontinued lisinopril, and angioedema might be more prevalent than ini­ her symptoms resolved within 24 hours. Mter her tially thought, and fatal cases have been de­ ACE inhibitor was discontinued, she experienced scribed.5-11 Many are not familiar with more symptoms and an increased frequency of late-onset angioedema associated with ACE in­ palpitations, but she had no change in exercise hibitors, and a delayed diagnosis can have poten­ tolerance. A cardiologist was consulted, who pre­ tially serious consequences.5,8-II scribed the angiotensin II (initially at dosages of 25 mg/d and then 50 mg/d). The was advised to report any

A 57-year-old African-American woman with symptoms or signs of angioedema immediately copyright. class 3 congestive caused by severe and to discontinue losartan if they occurred. mitral regurgitation came to the family medicine No side effects were observed after 18 months clinic with "swollen face and lips" of several of treatment. The patient's condition initially im­ hours' duration. She denied any breathing or proved with losartan (decreased fre­ swallowing difficulties. Her medical history was quency of palpitations), but her congestive heart negative for and angioedema. Her med­ failure gradually worsened, manifested as de­ ications included lisinopril 20 mg/d, 0.25 creasing exercise tolerance. An experimental in­ http://www.jabfm.org/ mg/d, furosemide 40 mg/d and cyclobenzaprine otropic drug was added to her regimen in March 10 mg at night, as needed. She had been taking 1996, 6 months after losartan therapy was initi­ lisinopril for 6 years without any problems. The ated. She is currently doing poorly and consider­ patient had been intermittently given cyclobenza­ ing cardiac transplantation. prine for recurrent low-back and never expe­ rienced any side effects. She had been off cy­ Discussion clobenzaprine for the past few months and had ACE inhibitors are prescribed widely for patients on 28 September 2021 by guest. Protected taken one 10-mg tablet the night before her who suffer from , congestive heart symptoms occurred. failure, and . These have a She had of her lower face and lips, but favorable side-effect profile and are generally well no evidence of swelling or respiratory tolerated. Most physicians are familiar with early­ compromise. Because she had recently restarted onset angioedema, which occurs within the first weeks of therapy. In 1992 Israili and HalP re­ viewed the literature on cough and angioedema Submitted, revised, Marcb 7, 1997. related to ACE inhibitors. Their conclusion was From the Department of Family Medicine, University of Ne­ that "angioneurotic edema usually occurs within braska Medical Center, Omaha. Address reprint requests to Adri­ ana]. Pavletic, MD, Department of Family Medicine, University hours or at most 1 week after starting the ACE of Nebraska Medical Center, 600 South 42nd St, Omaha, NE inhibitor; however, in one report, it developed af­ 68198-3075. ter long-term therapy with an ACE inhibitor."

370 }ABFP Sept.-Oct. 1997 Vol. 10No. 5 J Am Board Fam Pract: first published as 10.3122/jabfm.10.5.370 on 1 September 1997. Downloaded from Although diagnosing early-onset angioedema complexes, physical stimuli, or agents that pro­ should not pose a problem, many physicians are mote release. 13 not familiar with late-onset angioedema, and it ACE-inhibitor-associated angioedema is not an frequently goes unrecognized.5,8-11 In only one of allergic reaction. In most patients the disorder nine cases of angioedema associated with ACE occurs after starting ACE inhibitor therapy or af­ inhibitors treated at public in New ter switching from one ACE inhibitor to another Zealand was the patient advised to discontinue during a period that is too short for specific anti­ the ACE inhibitor. 11 In the present case, the diag­ bodies to develop.z Additional evidence against nosis was also initially missed because of a lack of an allergic basis for this is that the any temporal relation between the ACE inhibitor structurally unrelated ACE inhibitors induce sim­ and angioedema. Moreover, the cause of the ilar reactions. I4 The exact pathophysiologic edema was somewhat clouded because the patient mechanism of this rare side effect is unknown, restarted cyclobenzaprine the night before her but it is believed to be nonimmunogenic and re­ symptoms occurred. lated to increased levels of as a result The patient was seen the following day by a of inhibition of degradation.z-4 Angio­ family practice resident who, during her recent tensin-converting enzyme, also known as kini­ otolaryngology rotation, had become familiar nase II, degrades bradykinin. Consequently, in­ with late-onset angioedema associated With ACE hibition of ACE is thought to increase the inhibitor therapy. If she had not read Litman's ar­ concentration of bradykinin in tissues. IZ Only a ticle on late-onset angioedema,4 she would also very small number of patients develop this side have thought that the cyclobenzaprine was re­ effect, however, probably because of a combi­ sponsible. Although angioedema is listed as a nation of poorly understood host and environ­ possible side effect, there is no published medical mental factors. IZ Patients who have a history of literature on cyclobenzaprine-associated angio­ sporadic and might be at edema. Both the patient and her physician were increased for this and should copyright. convinced that the patient's angioedema was due not be given ACE inhibitors. I5,I6 African-Ameri­ to lisinopril, not cyclobenzaprine, as initially sus­ cans can also be at increased risk. 17 pected. This belief was confirmed when the pa­ The clinical manifestation is highly variable. tient resumed cyclobenzaprine therapy without Jason6 reported a case of a 70-year-old African­ any problems. American man who had been taking captopril for It is possible that the diagnosis was presump­ 2 years when he developed obstructive angio­

tive, because the patient was not rechallenged edema over 3.5 hours. Oral intubation was unsuc­ http://www.jabfm.org/ with lisinopril. Rechallenging might have been of cessful, and a difficult tracheostomy was too late no diagnostic value given that ACE-inhibitor­ to save the patient. In other instances symptoms associated angioedema is not an allergic reaction. are mild and can regress spontaneously while the That means that a negative result (ie, no symp­ patient continues the , thus erro­ toms after rechallenging) does not rule out a neously prompting an alternative diagnosisJ-9 1f cause-effect relation between ACE inhibitor and the diagnosis is missed, recurrent and more se­ angioedema, because angioedema can recur at vere episodes can occur with potentially serious on 28 September 2021 by guest. Protected any time after restarting the therapy. In a worst­ consequences.5,9 Litman et al 5 described 2 cases case scenario rechallenging could have caused a of life-threatening angioedema associated with severe, potentially fatal reaction. that required tracheostomy. One of the Angioedema can be sporadic (also known as id­ patients, who had experienced four previous iopathic) or hereditary. The sporadic subtype is episodes of tongue swelling, had been seen by the most common, with a 5 to 10 percent lifetime several physicians and given steroids and antihist­ risk for the general population. IO,I2 The heredi­ amines with relief of symptoms. Because of the tary form, which can be either allergic or nonal­ lack of a temporal relation, the enalapril had lergic, is much less common, with only 198 pa­ never been discontinued. tients described in the literature through 1983.2 Finley et al lO described the case of a patient Angioedema can occur with drug ingestion, C 1 who sought care from qualified emergency physi­ esterase-inhibitor deficiency, circulating immune cians for angioedema 18 times during a 3-year pe-

Angioedema and Use of ACE Inhibitors 371 J Am Board Fam Pract: first published as 10.3122/jabfm.10.5.370 on 1 September 1997. Downloaded from riod before the correct diagnosis was made. An­ tions for these and the longer duration of other case report described a patient who had an the treatment. Accordingly, ACE inhihitors 18-month history of recurrent swelling (at least should be considered in the 15 or 20 episodes) involving the left side of her of unexplained swelling of the face, lips, or face. This patient was examined hy several spe­ tongue or acute or recurrent ahdominal com­ cialists and underwent many diagnostic tests, in­ plaints in patients who are Oil ACE inhihitor cluding magnetic resonance imaging, before her therapy. problem was correctly diagnosed as angioedema associated with an ACE inhibitor.H References Unusual cases involving the gastrointestinal 1. Drug facts and comparisons. St. Louis, Mo: Facts tract have been reported. 1H- 20 Jacobs et aP8 de­ and Comparisons; 1995:165f. scribed a patient who had recurrent episodes of 2. Slater EE, Merrill DD, Guess HA, Roylance PJ, that was initially diagnosed as Cooper WD, Inman WH, et al. Clinical profile of Crohn . The patient failed to respond to a angioedema associated with angiotensin-converting enzyme inhibition. JAMA 1988;260:967 -70. course of prednisone and sulfasalazine. Her symptoms resolved after discontinuing the 3. Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting en­ enalapril. ACE inhibitors have recently been im­ zyme inhibitor therapy. A review of the literature plicated as a potential cause of acute , and pathophysiology. Ann Intern Med 1992; 117: with reports of cases associated with lisinopril, 234-42. captopril, and enalapril. 21 ,22 Angioedema of pan­ 4. Hedner T, Samuelsson 0, Lunde H, Lindholm L, creatic can result in obstruction of the duc­ Andren L, Wiholm BE. Angio-oedema in relation to tal system and lead to pancreatitis.23 ,24 treatment with angiotensin-converting enzyme in­ The mainstay of therapy is to stop taking the hibitors. BMJ 1992;304:941-6. offending drug. In mild cases such as the one de­ 5. Litman RS, Sher WH, Hausman SA. Life-threaten­ ing acute airway obstruction due to enalapril in­ copyright. scribed here, which involved the face and lips duced angioedema. Immunol Pract 1992; 14: without respiratory compromise, discontinuing 21-4. the drug is usually sufficient. More severe cases 6. Jason DR. Fatal angioedema associated with capto­ involving the tongue or causing respiratory com­ pril.] Forensic Sci 1992;37:1418-21. promise are treated with epinephrine, diphenhy­ 7. Venable RJ. Angioedema after long-term enalapril dramine, and steroids.2-4 Occasionally airway use.] Fam Pract 1992;34:201-4. protection is necessary and is sometimes difficult 8. Frontera Y, Piecuch JF. Multiple episodes of angio­ to accomplish.2-7 edema associated with lisinopril, an ACE inhibitor. http://www.jabfm.org/ ACE receptor antagonists lack the bradykinin­ J Am Dent Assoc 1995;126:217 -20. potentiating capacity and can be prescribed as al­ 9. Chin HL, Buchan DA. Severe angioedema after ternative therapy for patients who cannot tolerate long-term use of an angiotensin-converting enzyme inhibitor. Ann Intern Med 1990;112:312-3. ACE inhibitors, as implied by Goodfriend et aJ.25 to. Finley C], Silverman MA, Nunez AE. Angiotensin­ Angioedema has been reported with losartan, converting enzyme inhibitor-induced angioedema: however.26 In the present case, the benefits were still unrecognized. AnI] Emerg Med 1992;10:550-2. on 28 September 2021 by guest. Protected believed to outweigh the of treatment, and 11. Weiner JM. Failure to recognize the association of the patient was counseled on the possibility of an­ life-threatening angio-oedema and angiotensin-con­ gioedema. Losartan has not yet been approved verting enzyme inhibitor therapy. Aust N Z J Med for treatment of congestive heart failure, al­ 1995;25:241-2. though it is currently being evaluated in patients 12. O'Mara NB, O'Mara EM Jr. Delayed onset of an­ who previously had angioedema from an ACE in­ gioedema with angiotensin-converting enzyme in­ hibitors: case report and review of literature. Phar­ hibitor. l ] Early studies in patients with congestive macotherapy 1996; 16:675-9. heart failure suggest that losartan exerts the same 13. Megerian CA, Arnold]E, Berger M. Angioedema: 5 hemodynamic effects as do ACE inhibitors, re­ years' experience, with a review of the disorder's pre­ ducing afterload and increasing cardiac outputP sentation and treatment. Laryngoscope 1992; 102: The number of patients who have an adverse 256-60. reaction to ACE inhibitors will increase, given 14. Fine RM. The Fine Page: angiotensin-converting the growing numbers who are receiving prescrip- enzyme angioedema. Int] DermatoI1993;32:95-6.

372 ]ABFP Sept.-Oct. 1997 Vol. 10 No.5 J Am Board Fam Pract: first published as 10.3122/jabfm.10.5.370 on 1 September 1997. Downloaded from

15. Shepherd GM. Possible contraindications of an­ 21. Marinella MA, Billi ]E. Lisinopril therapy associated giotensin-converting enzyme inhibitors in patients with acute pancreatitis. West] Med 1995;163:77-8. with hereditary angioedema. Am] Med 1990;88: 22. Standridge ]B. Fulminant pancreatitis associated 446. with lisinopril therapy. South Med] 1994;87: 179- 16. Orfan N, Patterson R, Dykewicz MS. Severe an­ 81. gioedema related to ACE inhibitors in patients with 23. Dabaghi S. ACE inhibitors and pancreatitis. Ann In­ a history of idiopathic angioedema. ]AMA 1990; ternMed 1991;115:330-1. 264:1287-9. 17. Brown NJ, Ray WA, Snowden M, Griffin MR. Black 24. Marinella MA. Angio-oedema induced by ACE in­ hibitors.] Intern Med 1996;239:371-2. Americans have an increased rate of angiotensin converting enzyme inhibitors associated angio­ 25. Goodfrien~ TL, Elliot ME, Catt KJ. Angiotensin edema. Clin Pharmacol Ther 1996;60:8-13. receptors and their antagonists. N Engl] Med 1996; 18. Jacobs RL, Hoberman L], Goldstein HM. An­ 334:1649~54. gioedema of the small bowel caused by an angio­ 26. Acker CG, Greenberg A. Angioedema induced by tensin-converting enzyme inhibitor. Am] Gastroen­ the angiotensin II blocker losartan. N Engl] Med terol1994;89:127-8. 1995;333:1572. 19. Gregory KW, Davis RC. Angioedema of the intes­ 27. Crozier I, Ikram H, Awan N, Cleland], Stephen N, tine. N EnglJ Med 1996;334: 1641. Dickstein K, et al. Losartan in heart failure. Hemo­ 20. Pavletic A]. Angioedema of the intestine. N EnglJ dynamic effects and . Losartan Hemody­ Med 1996;335:1534. Letter. namic Study Group. Circulation 1995;91:691-7. copyright. http://www.jabfm.org/ on 28 September 2021 by guest. Protected

Angioedema and Use of ACE Inhibitors 373